Table 2

CCyR at 3, 6, and 12 months by therapy

3 months6 months12 months
EvaluableCCyR%PEvaluableCCyR%PEvaluableCCyR%P
IM 400 mg702739703753684566
IM 800 mg19912563< .00119416485< .00118716990< .001
Second TKI141114811311259511811698
  • Evaluable indicates patients who received therapy and were evaluable for cytogenetic response at each time point; and IM, imatinib.